Report Feature
The future of the gene expression market looks promising with opportunities in drug discovery & development, clinical diagnostic, and biotechnology & microbiology applications. The global gene expression market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are decreasing cost of sequencing, technological advancements, rising prevalence of cancer, availability of government funding, novel technologies to aid gene expression studies, growing application areas of gene expression, and availability of gene expression databases.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global gene expression market report, please download the report brochure.
In this market, consumables is the largest product & service segment of gene expression, whereas pharmaceutical & biotechnology companies is the largest end user. Growth in various segments of the gene expression market are given below:
The study includes trends and forecast for the global gene expression market by product and service, process, capacity, technique, application, end user, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Consumables
- Kits and Reagents
- DNA Chips
-
Instruments
- PCR
- NGS
- DNA Microarray
- Others
-
Services
-
Gene Expression Profiling Services
- Sequencing Services
- Other Services
- Bioinformatics Solutions
-
Gene Expression Profiling Services
By Process [Value ($ Million) shipment analysis for 2014 – 2025]:
- Sample Collection
- Purification
- cDNA Synthesis & Conversion
- PCR Analysis
- Data Analysis & Interpretation
By Capacity [Value ($ Million) shipment analysis for 2014 – 2025]:
- Low- to Mid- Plex
- High-Plex
By Technique [Value ($ Million) shipment analysis for 2014 – 2025]:
-
RNA Expression
- Northern Blotting
- DNA Microarrays
- PCR Techniques
- RNA-Seq
-
Promoter Analysis
- In-vitro Transcription/Nuclear Run-On Assays
- Gel Shift Assays
- Chromatin Immunoprecipitation (ChIP)
-
Protein Expression & Posttranslational Modification Analysis
- Western Blotting
- 2-D Gel Electrophoresis
- Immunoassays
- Mass Spectrometry
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Drug Discovery & Development
- Clinical Diagnostics
- Biotechnology & Microbiology
- Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Pharmaceutical and Biotech companies
- Academic Institutes and Research Centers
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the gene expression companies profiled in this report include Illumina, Thermo Fisher Scientific, Bio-Rad Laboratories, F. Hoffmann-La Roche, GE Healthcare, Pacific Biosciences of California, Agilent Technologies, QIAGEN, Oxford Gene Technologies, and Eurofins Scientific.
Lucintel forecasts that kits and reagents will remain the largest product and service segment over the forecast period, driven by higher usage of these products, low price, launch of novel kits and reagents with enhanced efficiency, and rising demand for better data interpretation & visualization.
Within this market, pharmaceutical and biotechnology companies will remain the largest end user segment over the forecast period due to utilization of gene expression analysis products and services to achieve clinical research goals, increasing focus on developing targeted therapies, and increasing in the demand for gene expression analysis services offered by CROs.
North America will remain the largest region, and it is also expected to witness the highest growth over the forecast period due to the presence of a substantial number of well-established players in the region, increased focus on advanced healthcare, government support to initiatives that promote precision medicines, and high investments in genomic research.
|
Features of the Global Gene Expression Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global gene expression market by product and service (consumables (kits and reagents and DNA chips), instruments (PCR, NGS, DNA microarray, and others), and services (gene expression profiling services (sequencing services and other services) and bioinformatics solutions), process (sample collection, purification, cDNA synthesis & conversion, PCR analysis, and data analysis & interpretation), capacity (low- to mid- plex and high-plex), technique (RNA expression (northern blotting, DNA microarrays, PCR techniques, and RNA-seq), promoter analysis (in vitro transcription/nuclear run-on assays, gel shift assays, and chromatin immunoprecipitation (ChIP)), and protein expression & posttranslational modification analysis (western blotting, 2-D gel electrophoresis, immunoassays, and mass spectrometry), application (drug discovery & development, clinical diagnostics, biotechnology & microbiology, and others), end user (pharmaceutical and biotech companies, academic institutes and research centers, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global gene expression market? Q.5 What are the business risks and threats to the global gene expression market? Q.6 What are the emerging trends in this gene expression market and the reasons behind them? Q.7 What are some changing demands of customers in this gene expression market? Q.8 What are the new developments in this gene expression market? Which companies are leading these developments? Q.9 Who are the major players in this gene expression market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this gene expression market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global gene expression market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product and Service (Consumables (Kits and Reagents and DNA Chips), Instruments (PCR, NGS, DNA Microarray, and Others), and Services (Gene Expression Profiling Services (Sequencing Services and Other Services) and Bioinformatics Solutions), Process (Sample Collection, Purification, Cdna Synthesis & Conversion, PCR Analysis, and Data Analysis & Interpretation), Capacity (Low- To Mid- Plex and High-Plex), Technique (RNA Expression (Northern Blotting, DNA Microarrays, PCR Techniques, and RNA-Seq), Promoter Analysis (In Vitro Transcription/Nuclear Run-On Assays, Gel Shift Assays, and Chromatin Immunoprecipitation (Chip)), and Protein Expression & Posttranslational Modification Analysis (Western Blotting, 2-D Gel Electrophoresis, Immunoassays, and Mass Spectrometry), Application (Drug Discovery & Development, Clinical Diagnostics, Biotechnology & Microbiology, and Others), and End User (Pharmaceutical and Biotech Companies, Academic Institutes and Research Centers, and Others) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (Norway, Spain, Germany, and France), Asia (China, India, Vietnam, and Indonesia), and ROW (Chile and Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Gene Expression Market
4.1 Global Gene Expression Market by Region
4.2.1 Market by Product and Service: Consumables (Kits and Reagents and DNA Chips), Instruments (PCR, NGS, DNA Microarray, and Others), and Services (Gene Expression Profiling Services (Sequencing Services and Other Services) and Bioinformatics Solutions)
4.2.2 Market by Process: Sample Collection, Purification, Cdna Synthesis & Conversion, PCR Analysis, and Data Analysis & Interpretation
4.2.3 Market by Capacity: Low- to Mid- Plex and High-Plex
4.2.4 Market by Technique: RNA Expression (Northern Blotting, DNA Microarrays, PCR Techniques, and RNA-Seq), Promoter Analysis (In-Vitro Transcription/Nuclear Run-On Assays, Gel Shift Assays, and Chromatin Immunoprecipitation (Chip)), and Protein Expression & Posttranslational Modification Analysis (Western Blotting, 2-D Gel Electrophoresis, Immunoassays, and Mass Spectrometry)
4.2.5 Market by Application: Drug Discovery & Development, Clinical Diagnostics, Biotechnology & Microbiology, and Others
4.2.6 Market by End User: Pharmaceutical and Biotech Companies, Academic Institutes and Research Centers, and Others
4.2.7 The United States Gene Expression Market
4.2.8 The Canadian Gene Expression Market
4.2.9 The Mexican Gene Expression Market
4.3.1 Market by Product and Service: Consumables (Kits and Reagents and DNA Chips), Instruments (PCR, NGS, DNA Microarray, and Others), and Services (Gene Expression Profiling Services (Sequencing Services and Other Services) and Bioinformatics Solutions)
4.3.2 Market by Process: Sample Collection, Purification, Cdna Synthesis & Conversion, PCR Analysis, and Data Analysis & Interpretation
4.3.3 Market by Capacity: Low- to Mid- Plex and High-Plex
4.3.4 Market by Technique: RNA Expression (Northern Blotting, DNA Microarrays, PCR Techniques, and RNA-Seq), Promoter Analysis (In-Vitro Transcription/Nuclear Run-On Assays, Gel Shift Assays, and Chromatin Immunoprecipitation (Chip)), and Protein Expression & Posttranslational Modification Analysis (Western Blotting, 2-D Gel Electrophoresis, Immunoassays, and Mass Spectrometry)
4.3.5 Market by Application: Drug Discovery & Development, Clinical Diagnostics, Biotechnology & Microbiology, and Others
4.3.6 Market by End User: Pharmaceutical and Biotech Companies, Academic Institutes and Research Centers, and Others
4.3.7 The United Kingdom Gene Expression Market
4.3.8 The Spanish Gene Expression Market
4.3.9 The German Gene Expression Market
4.3.10 The French Gene Expression Market
4.4.1 Market by Product and Service: Consumables (Kits and Reagents and DNA Chips), Instruments (PCR, NGS, DNA Microarray, and Others), and Services (Gene Expression Profiling Services (Sequencing Services and Other Services) and Bioinformatics Solutions)
4.4.2 Market by Process: Sample Collection, Purification, Cdna Synthesis & Conversion, PCR Analysis, and Data Analysis & Interpretation
4.4.3 Market by Capacity: Low- to Mid- Plex and High-Plex
4.4.4 Market by Technique: RNA Expression (Northern Blotting, DNA Microarrays, PCR Techniques, and RNA-Seq), Promoter Analysis (In-Vitro Transcription/Nuclear Run-On Assays, Gel Shift Assays, and Chromatin Immunoprecipitation (Chip)), and Protein Expression & Posttranslational Modification Analysis (Western Blotting, 2-D Gel Electrophoresis, Immunoassays, and Mass Spectrometry)
4.4.5 Market by Application: Drug Discovery & Development, Clinical Diagnostics, Biotechnology & Microbiology, and Others
4.4.6 Market by End User: Pharmaceutical and Biotech Companies, Academic Institutes and Research Centers, and Others
4.4.7 The Chinese Gene Expression Market
4.4.8 The Indian Gene Expression Market
4.4.9 The Japanese Gene Expression Market
4.5.1 Market by Product and Service: Consumables (Kits and Reagents and DNA Chips), Instruments (PCR, NGS, DNA Microarray, and Others), and Services (Gene Expression Profiling Services (Sequencing Services and Other Services) and Bioinformatics Solutions)
4.5.2 Market by Process: Sample Collection, Purification, Cdna Synthesis & Conversion, PCR Analysis, and Data Analysis & Interpretation
4.5.3 Market by Capacity: Low- to Mid- Plex and High-Plex
4.5.4 Market by Technique: RNA Expression (Northern Blotting, DNA Microarrays, PCR Techniques, and RNA-Seq), Promoter Analysis (In-Vitro Transcription/Nuclear Run-On Assays, Gel Shift Assays, and Chromatin Immunoprecipitation (Chip)), and Protein Expression & Posttranslational Modification Analysis (Western Blotting, 2-D Gel Electrophoresis, Immunoassays, and Mass Spectrometry)
4.5.5 Market by Application: Drug Discovery & Development, Clinical Diagnostics, Biotechnology & Microbiology, and Others
4.5.6 Market by End User: Pharmaceutical and Biotech Companies, Academic Institutes and Research Centers, and Others
4.5.7 Brazilian Gene Expression Market
7.1.1 Growth Opportunities for the Global Gene Expression Market by Product and Service
7.1.2 Growth Opportunities for the Global Gene Expression Market by Process
7.1.3 Growth Opportunities for the Global Gene Expression Market by Capacity
7.1.4 Growth Opportunities for the Global Gene Expression Market by Technique
7.1.5 Growth Opportunities for the Global Gene Expression Market by Application
7.1.6 Growth Opportunities for the Global Gene Expression Market by End User
7.1.7 Growth Opportunities for the Global Gene Expression Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
